These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16316451)

  • 1. Malignancy-induced autoimmunity to MUC1: initial antibody characterization.
    Graves CR; Robertson JF; Murray A; Price MR; Chapman CJ
    J Pept Res; 2005 Dec; 66(6):357-63. PubMed ID: 16316451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibody recognition of synthetic antigens from MUC1.
    Bánóczi Z; Mezõ G; Windberg E; Uray K; Majer Z; Hudecz F
    J Pept Sci; 2008 May; 14(5):610-6. PubMed ID: 17975847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
    Schuman JT; Grinstead JS; Apostolopoulos V; Campbell AP
    Biopolymers; 2005 Feb; 77(2):107-20. PubMed ID: 15635690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a secreted MUC1/SEC protein by MUC1 isoform specific monoclonal antibodies.
    Smorodinsky N; Weiss M; Hartmann ML; Baruch A; Harness E; Yaakobovitz M; Keydar I; Wreschner DH
    Biochem Biophys Res Commun; 1996 Nov; 228(1):115-21. PubMed ID: 8912645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1.
    Ryuko K; Schol DJ; Snijdewint FG; von Mensdorff-Pouilly S; Poort-Keesom RJ; Karuntu-Wanamarta YA; Verstraeten RA; Miyazaki K; Kenemans P; Hilgers J
    Tumour Biol; 2000; 21(4):197-210. PubMed ID: 10867613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Pepscan analyses for epitope mapping of anti-MUC1 monoclonal antibodies--a comparative study and review of five antibodies.
    Petrakou E; Murray A; Rosamund C; Graves L; Price MR
    Anticancer Res; 1998; 18(6A):4419-21. PubMed ID: 9891503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21.
    Adluri S; Gilewski T; Zhang S; Ramnath V; Ragupathi G; Livingston P
    Br J Cancer; 1999 Apr; 79(11-12):1806-12. PubMed ID: 10206297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC-restricted presentation of a single repeat of MUC1 mucin.
    Orr MK; Burnside JS; Phillips CA; Philip R; Dombrowski KE; Wright SE
    Immunol Invest; 2007; 36(3):271-83. PubMed ID: 17558710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
    Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancer.
    Yamamoto K; Ueno T; Kawaoka T; Hazama S; Fukui M; Suehiro Y; Hamanaka Y; Ikematsu Y; Imai K; Oka M; Hinoda Y
    Anticancer Res; 2005; 25(5):3575-9. PubMed ID: 16101182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, Calif., November 17-23, 1996.
    Price MR; Rye PD; Petrakou E; Murray A; Brady K; Imai S; Haga S; Kiyozuka Y; Schol D; Meulenbroek MF; Snijdewint FG; von Mensdorff-Pouilly S; Verstraeten RA; Kenemans P; Blockzjil A; Nilsson K; Nilsson O; Reddish M; Suresh MR; Koganty RR; Fortier S; Baronic L; Berg A; Longenecker MB; Hilgers J
    Tumour Biol; 1998; 19 Suppl 1():1-20. PubMed ID: 9422084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.
    von Mensdorff-Pouilly S; Petrakou E; Kenemans P; van Uffelen K; Verstraeten AA; Snijdewint FG; van Kamp GJ; Schol DJ; Reis CA; Price MR; Livingston PO; Hilgers J
    Int J Cancer; 2000 Jun; 86(5):702-12. PubMed ID: 10797294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
    von Mensdorff-Pouilly S; Gourevitch MM; Kenemans P; Verstraeten AA; van Kamp GJ; Kok A; van Uffelen K; Snijdewint FG; Paul MA; Meijer S; Hilgers J
    Tumour Biol; 1998; 19(3):186-95. PubMed ID: 9591045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to MUC1 in women with a BRCA1 or BRCA2 mutation.
    Hermsen BB; Verheijen RH; Menko FH; Gille JJ; van Uffelen K; Blankenstein MA; Meijer S; van Diest PJ; Kenemans P; von Mensdorff-Pouilly S
    Eur J Cancer; 2007 Jul; 43(10):1556-63. PubMed ID: 17532207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 autoantibodies from patients with colorectal cancer recognize common epitopes in the N- or C-terminus of p53.
    Saleh J; Kreissler-Haag D; Montenarh M
    Int J Oncol; 2004 Oct; 25(4):1149-55. PubMed ID: 15375567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.